HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Prolonged molecular remission after autologous stem cell transplantation in relapsed acute promyelocytic leukemia.

Abstract
Six patients with relapsed acute promyelocytic leukemia (APL) received autologous stem cell transplantation (ASCT) in second (n=5) or fourth (n=1) molecular remission with a molecularly negative graft. After a median follow-up of 33 months from ASCT, 5 patients are alive in molecular remission and one died 27 months after autograft from refractory relapse.
AuthorsFelicetto Ferrara, Salvatore Palmieri, Mario Annunziata, Barbara Pocali, Assunta Viola, Fabrizio Pane
JournalHaematologica (Haematologica) Vol. 89 Issue 5 Pg. 621-2 (May 2004) ISSN: 1592-8721 [Electronic] Italy
PMID15136233 (Publication Type: Letter)
Topics
  • Adolescent
  • Adult
  • Aged
  • Female
  • Humans
  • Leukemia, Promyelocytic, Acute (therapy)
  • Male
  • Recurrence
  • Remission Induction
  • Stem Cell Transplantation
  • Transplantation, Autologous

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: